首页> 外文会议>Falk Symposium >Pharmacogenetics of inflammatory bowel disease therapy
【24h】

Pharmacogenetics of inflammatory bowel disease therapy

机译:炎症性肠病疗法的药物遗传学

获取原文

摘要

The response of individual patients to the same drug given in the same dose varies considerably for several substances. Many patients will expect the desired drug effect, some may suffer from well-known adverse drug reactions, others may experience no effects, and very rarely a patient will die from severe side-effects. It is currently very difficult for physicians to prescribe the optimal drug in the optimal dose for each patient, since prediction of a patient's response to a specific drug is rarely possible. From a clinical point of view, excessive numbers of patients suffer from adverse drug reactions. In the USA such reactions are estimated to be from the fourth to sixth leading cause of deaths in hospital patients1. In addition, the cost burden is tremendous. A large percentage of health budgets are spent on inefficient drug therapy. The application of pharmacogenetic knowledge offers the opportunity of individually tailored, safe and efficient drug treatment.
机译:对于几种物质,各个患者对同一剂量相同药物的响应会变化很大。许多患者将期望所需的药物效应,有些可能患有众所周知的不良药物反应,其他可能可能会出现任何影响,并且很少患者将死于严重的副作用。目前,医生在每位患者的最佳剂量中规定最佳药物是非常困难的,因为很少可能预测患者对特定药物的反应。从临床角度来看,过量的患者患有不良药物反应。在美国,这种反应估计来自医院患者死亡的第四至第六个主要原因。此外,成本负担是巨大的。在效率低下的药物治疗中花费了大量的健康预算。药物发生知识的应用提供了单独量身定制,安全高效的药物治疗机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号